
Amitant-IV Injection
Marketer
Aureate Healthcare Pvt Ltd
Salt Composition
Fosaprepitant (150mg)
Overview Amitant-IV Injection
Oncaspar-IV is a prescription medication administered to counteract chemotherapy-induced nausea and vomiting. This injection must be given by a healthcare provider. Consistent dosing is crucial; discontinuation requires prior consultation with your physician. Missed doses should be taken as soon as recalled, completing the prescribed course regardless of symptom improvement. Your doctor might recommend regular liver function tests during treatment. Potential side effects include fatigue, headache, appetite loss, constipation, and hiccups. Drowsiness and dizziness are also possible; avoid driving or activities demanding concentration until the medication's effects are known.
Uses of Amitant-IV Injection
Chemotherapy-induced emesis
Major Benefits of Amitant-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Amitant-IV Injection:
- Headache
- Hiccup
- Indigestion
- Fatigue
- Decreased appetite
- Constipation
How to use Amitant-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Amitant-IV Injection works:
Oncaspar injection is an anti-nausea drug. Its mechanism involves inhibiting a brain neurotransmitter (neurokinin) responsible for chemotherapy-induced emesis.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Amitant-IV Injection is contraindicated.
PregnancySAFE IF PRESCRIBED
The intravenous administration of Amitant is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCONSULT YOUR DOCTOR
Use of Amitant-IV Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Amitant-IV may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Administration of Amitant-IV Injection is considered safe for individuals with renal impairment. No alteration of the Amitant-IV Injection dosage is advised.
LiverCAUTION
Exercise caution when administering Amitant-IV Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alterations are not advised for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Amitant-IV Injection :
Should you forget a dose of Amitant-IV Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Amitant-IV Injection
| Label | Value |
|---|---|
| Type of Compound | Morphinan derivative |
| Potential for Dependence | None. |
| Type of Medication | Stomach and bowel |
| Mechanism of Action | Substance P receptor blockers |
